1.Detection of Tick-Borne Pathogens in the Korean Water Deer (Hydropotes inermis argyropus) from Jeonbuk Province, Korea.
Giyong SEONG ; Yu Jung HAN ; Sung Suck OH ; Joon Seok CHAE ; Do Hyeon YU ; Jinho PARK ; Bae Keun PARK ; Jae Gyu YOO ; Kyoung Seong CHOI
The Korean Journal of Parasitology 2015;53(5):653-659
The objective of this study was to investigate the prevalence of tick-borne pathogens in the Korean water deer (Hydropotes inermis argyropus). Pathogens were identified using PCR which included Anaplasma, Ehrlichia, Rickettsia, and Theileria. Rickettsia was not detected, whereas Anaplasma, Ehrlichia, and Theileria infections were detected in 4, 2, and 8 animals, respectively. The most prevalent pathogen was Theileria. Of the 8 Theileria-positive animals, 2 were mixed-infected with 3 pathogens (Anaplasma, Ehrlichia, and Theileria) and another 2 animals showed mixed-infection with 2 pathogens (Anaplasma and Theileria). Sequencing analysis was used to verify the PCR results. The pathogens found in this study were identified as Anaplasma phagocytophilum, Ehrlichia canis, and Theileria sp. To the best of our knowledge, this is the first report identifying these 3 pathogens in the Korean water deer. Our results suggest that the Korean water deer may serve as a major reservoir for these tick-borne pathogens, leading to spread of tick-borne diseases to domestic animals, livestock, and humans. Further studies are needed to investigate their roles in this respect.
Anaplasma/isolation & purification
;
Animals
;
Bacterial Infections/epidemiology/microbiology/*veterinary
;
Cluster Analysis
;
Coinfection/epidemiology/microbiology/veterinary
;
DNA, Bacterial/chemistry/genetics
;
DNA, Ribosomal/chemistry/genetics
;
Ehrlichia/*isolation & purification
;
Korea/epidemiology
;
Molecular Sequence Data
;
Phylogeny
;
Prevalence
;
RNA, Ribosomal, 16S/genetics
;
Rickettsia/*isolation & purification
;
Ruminants/*microbiology
;
Sequence Analysis, DNA
;
Theileria/*isolation & purification
2.Detection of Anaplasma sp. in Korean Native Goats (Capra aegagrus hircus) on Jeju Island, Korea.
Giyong SEONG ; Yu Jung HAN ; Jeong Byoung CHAE ; Joon Seok CHAE ; Do Hyeon YU ; Young Sung LEE ; Jinho PARK ; Bae Keun PARK ; Jae Gyu YOO ; Kyoung Seong CHOI
The Korean Journal of Parasitology 2015;53(6):765-769
Anaplasma species are obligate intracellular pathogens that can cause tick-borne diseases in mammalian hosts. To date, very few studies of their occurrence in Korean native goats (Capra aegagrus hircus) have been reported. In the present study, we investigated Anaplasma infection of Korean native goats on Jeju Island, Republic of Korea, and performed phylogenetic analysis based on the 16S rRNA gene sequences. Our results showed that Anaplasma infection was found mostly in adult female goats. The phylogenetic tree revealed that the 7 sequences identified in Korean native goats could belong to Anaplasma sp. and were distinct from A. marginale, A. centrale, and A. ovis. The results indicated that the sequences identified to belong to Anaplasma were closely related to sequences isolated from goats in China and were clustered within the same group. To our knowledge, this is the first study to detect Anaplasma sp. infection in Korean native goats.
Anaplasma/classification/genetics/*isolation & purification
;
Anaplasmosis/*microbiology
;
Animals
;
Female
;
Goat Diseases/*microbiology
;
Goats
;
Islands
;
Male
;
Molecular Sequence Data
;
Phylogeny
;
Republic of Korea
3.Identification of New Pathogenic Variants of Hereditary Diffuse Gastric Cancer
Seung-Young OH ; Giyong JANG ; Jaeryuk KIM ; Kyoung-Yun JEONG ; Hyun Myong KIM ; Yoon Jin KWAK ; Seong-Ho KONG ; Do Joong PARK ; Hyuk-Joon LEE ; Sung-Yup CHO ; Jong-Il KIM ; Han-Kwang YANG
Cancer Research and Treatment 2024;56(4):1126-1135
Purpose:
Hereditary diffuse gastric cancer (HDGC) presents a significant genetic predisposition, notably linked to mutations in the CDH1 and CTNNA1. However, the genetic basis for over half of HDGC cases remains unidentified. The aim of this study is to identify novel pathogenic variants in HDGC and evaluate their protein expression.
Materials and Methods:
Among 20 qualifying families, two were selected based on available pedigree and DNA. Whole genome sequencing (WGS) on DNA extracted from blood and whole exome sequencing on DNA from formalin-fixed paraffin-embedded tissues were performed to find potential pathogenic variants in HDGC. After selection of a candidate variant, functional validation, and enrichment analysis were performed.
Results:
As a result of WGS, three candidate germline mutations (EPHA5, MCOA2, and RHOA) were identified in one family. After literature review and in-silico analyses, the RHOA mutation (R129W) was selected as a candidate. This mutation was found in two gastric cancer patients within the family. In functional validation, it showed RhoA overexpression and a higher GTP-bound state in the RhoaR129W mutant. Decreased phosphorylation at Ser127/397 suggested altered YAP1 regulation in the Rho-ROCK pathway. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses linked RhoaR129W overexpression to changed migration/adhesion in MKN1 cell line. However, this RHOA mutation (R129W) was not found in index patients in other families.
Conclusion
The RHOA mutation (R129W) emerges as a potential causative gene for HDGC, but only in one family, indicating a need for further studies to understand its role in HDGC pathogenesis fully.
4.Identification of New Pathogenic Variants of Hereditary Diffuse Gastric Cancer
Seung-Young OH ; Giyong JANG ; Jaeryuk KIM ; Kyoung-Yun JEONG ; Hyun Myong KIM ; Yoon Jin KWAK ; Seong-Ho KONG ; Do Joong PARK ; Hyuk-Joon LEE ; Sung-Yup CHO ; Jong-Il KIM ; Han-Kwang YANG
Cancer Research and Treatment 2024;56(4):1126-1135
Purpose:
Hereditary diffuse gastric cancer (HDGC) presents a significant genetic predisposition, notably linked to mutations in the CDH1 and CTNNA1. However, the genetic basis for over half of HDGC cases remains unidentified. The aim of this study is to identify novel pathogenic variants in HDGC and evaluate their protein expression.
Materials and Methods:
Among 20 qualifying families, two were selected based on available pedigree and DNA. Whole genome sequencing (WGS) on DNA extracted from blood and whole exome sequencing on DNA from formalin-fixed paraffin-embedded tissues were performed to find potential pathogenic variants in HDGC. After selection of a candidate variant, functional validation, and enrichment analysis were performed.
Results:
As a result of WGS, three candidate germline mutations (EPHA5, MCOA2, and RHOA) were identified in one family. After literature review and in-silico analyses, the RHOA mutation (R129W) was selected as a candidate. This mutation was found in two gastric cancer patients within the family. In functional validation, it showed RhoA overexpression and a higher GTP-bound state in the RhoaR129W mutant. Decreased phosphorylation at Ser127/397 suggested altered YAP1 regulation in the Rho-ROCK pathway. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses linked RhoaR129W overexpression to changed migration/adhesion in MKN1 cell line. However, this RHOA mutation (R129W) was not found in index patients in other families.
Conclusion
The RHOA mutation (R129W) emerges as a potential causative gene for HDGC, but only in one family, indicating a need for further studies to understand its role in HDGC pathogenesis fully.
5.Identification of New Pathogenic Variants of Hereditary Diffuse Gastric Cancer
Seung-Young OH ; Giyong JANG ; Jaeryuk KIM ; Kyoung-Yun JEONG ; Hyun Myong KIM ; Yoon Jin KWAK ; Seong-Ho KONG ; Do Joong PARK ; Hyuk-Joon LEE ; Sung-Yup CHO ; Jong-Il KIM ; Han-Kwang YANG
Cancer Research and Treatment 2024;56(4):1126-1135
Purpose:
Hereditary diffuse gastric cancer (HDGC) presents a significant genetic predisposition, notably linked to mutations in the CDH1 and CTNNA1. However, the genetic basis for over half of HDGC cases remains unidentified. The aim of this study is to identify novel pathogenic variants in HDGC and evaluate their protein expression.
Materials and Methods:
Among 20 qualifying families, two were selected based on available pedigree and DNA. Whole genome sequencing (WGS) on DNA extracted from blood and whole exome sequencing on DNA from formalin-fixed paraffin-embedded tissues were performed to find potential pathogenic variants in HDGC. After selection of a candidate variant, functional validation, and enrichment analysis were performed.
Results:
As a result of WGS, three candidate germline mutations (EPHA5, MCOA2, and RHOA) were identified in one family. After literature review and in-silico analyses, the RHOA mutation (R129W) was selected as a candidate. This mutation was found in two gastric cancer patients within the family. In functional validation, it showed RhoA overexpression and a higher GTP-bound state in the RhoaR129W mutant. Decreased phosphorylation at Ser127/397 suggested altered YAP1 regulation in the Rho-ROCK pathway. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses linked RhoaR129W overexpression to changed migration/adhesion in MKN1 cell line. However, this RHOA mutation (R129W) was not found in index patients in other families.
Conclusion
The RHOA mutation (R129W) emerges as a potential causative gene for HDGC, but only in one family, indicating a need for further studies to understand its role in HDGC pathogenesis fully.
6.Identification of New Pathogenic Variants of Hereditary Diffuse Gastric Cancer
Seung-Young OH ; Giyong JANG ; Jaeryuk KIM ; Kyoung-Yun JEONG ; Hyun Myong KIM ; Yoon Jin KWAK ; Seong-Ho KONG ; Do Joong PARK ; Hyuk-Joon LEE ; Sung-Yup CHO ; Jong-Il KIM ; Han-Kwang YANG
Cancer Research and Treatment 2024;56(4):1126-1135
Purpose:
Hereditary diffuse gastric cancer (HDGC) presents a significant genetic predisposition, notably linked to mutations in the CDH1 and CTNNA1. However, the genetic basis for over half of HDGC cases remains unidentified. The aim of this study is to identify novel pathogenic variants in HDGC and evaluate their protein expression.
Materials and Methods:
Among 20 qualifying families, two were selected based on available pedigree and DNA. Whole genome sequencing (WGS) on DNA extracted from blood and whole exome sequencing on DNA from formalin-fixed paraffin-embedded tissues were performed to find potential pathogenic variants in HDGC. After selection of a candidate variant, functional validation, and enrichment analysis were performed.
Results:
As a result of WGS, three candidate germline mutations (EPHA5, MCOA2, and RHOA) were identified in one family. After literature review and in-silico analyses, the RHOA mutation (R129W) was selected as a candidate. This mutation was found in two gastric cancer patients within the family. In functional validation, it showed RhoA overexpression and a higher GTP-bound state in the RhoaR129W mutant. Decreased phosphorylation at Ser127/397 suggested altered YAP1 regulation in the Rho-ROCK pathway. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses linked RhoaR129W overexpression to changed migration/adhesion in MKN1 cell line. However, this RHOA mutation (R129W) was not found in index patients in other families.
Conclusion
The RHOA mutation (R129W) emerges as a potential causative gene for HDGC, but only in one family, indicating a need for further studies to understand its role in HDGC pathogenesis fully.